当前位置:主页 > 医学论文 > 泌尿论文 >

晚期超高PSA型前列腺癌的临床特征及诊治分析

发布时间:2018-07-18 17:23
【摘要】:目的探讨晚期血清超高前列腺特异性抗原(prostate specific antigen,PSA)型前列腺癌患者的临床特点和诊疗方法,提高对该类患者的诊疗水平。方法回顾性分析自2009年12月至2014年2月我科收治的28例首诊时血清PSA水平超过500ng/ml的前列腺癌患者的临床资料,分析该类患者的发病年龄、确诊方法、病理结果、治疗方案以及预后,总结该类患者的临床特点,同时取同时期首诊血清PSA低于500ng/ml的前列腺癌患者作为对照组,比较二者的发病年龄、病理结果、治疗方案以及预后等有无差异。结果所有入组的28例患者在确诊后均给予黄体生成素释放激素类似物(LHRH-α)及雄激素拮抗剂等药物行内分泌治疗,其中行“比卡鲁胺片+醋酸戈舍瑞林缓释植入剂”治疗的患者有14例(50%),行“比卡鲁胺片+注射用醋酸亮丙瑞林”治疗的患者有14例(50%),患者应用内分泌药物后其血清睾酮及PSA迅速下降,临床症状缓解;用药后有9例(32.1%)出现ED及性欲丧失症状,结合患者高龄等因素,未予以处理;7例(25%)患者出现面色潮红,1个月后,该类副作用明显减轻;2例(7.1%)出现胰岛素抵抗,建议至内分泌科诊疗,给予口服药物治疗,现患者血糖正常;1例(3.6%)患者出现男性乳房发育,3个月后症状消失。有12例患者同期行125I粒子植入治疗,治疗后10例患者疾病控制可,另外两例疾病进展,分别出现左肾和盆腔淋巴结转移,后给予二者以多西他赛为基础的化疗方案治疗;患者行125I治疗后有5例出现轻至中度的下尿路症状(LUTS)及肛门会阴区不适,有3例出现暂时性的排便习惯改变或里急后重等直肠刺激症状,2例患者在术后前3天内出现直肠出血症状,远期观察未见患者出现尿道狭窄、直肠前列腺瘘等重大不良反应。28例患者中有20例在确诊时即已出现全身多发骨转移现象,该类患者中7例患者行锶(89)治疗,另外13例患者行因卡膦酸二钠治疗。行89锶治疗的患者中只有1例出现原骨骼病灶增大和新发骨骼转移灶,另外6例患者未发现有新发骨骼病变;给予因卡膦酸二钠治疗的13例患者中,有4例患者治疗过程中出现新发骨骼病变,其他9例患者未出现骨骼病变,两种方法相比对骨骼的保护作用没有统计学意义(P>0.05)。所有患者治疗过程中有18例患者进展为去势抵抗前列腺癌(castrationresistant prostate cancer,CRPC),该类患者从一线内分泌治疗开始至进展为CRPC的时间最长为21个月,最短为7个月,中位时间为13个月。患者进展为CRPC后在坚持行内分泌治疗的同时,有3例患者对新发病灶行外放射治疗后病情稳定,9例患者在给予以多西他赛为基础的行化疗方案治疗,化疗后生存期最短的为2号患者,时间为2个月,最长的为17号患者,生存时间为9个月,化疗过程中2例(7.1%)患者出现粒细胞减少性发热,给予粒细胞集落刺激因子后,症状改善;1例(3.6%)患者化疗起始阶段出现腹泻,对症治疗后症状消失;1例1例(3.6%)患者存在肢体麻木感,化疗后第3~6天,症状消失;余未见其他不良反应。另有6例出现新发骨骼病灶的CRPC患者采用“茵福+89锶”治疗后,,患者病情稳定。本研究随访6~48个月,平均随访17.9个月,21.5%(6例)患者死于前列腺癌所引起的并发症,7.0%(2例)患者死于恶病质,1例(3.6%)患者因肝脏衰竭而死亡,死于心脏衰竭的患者1例(3.6%),1例(3.6%)患者因长期卧床死于坠积性肺炎,1例(3.6%)患者死于心肌梗塞,其余16例截至2014年2月仍在随访中,未见重大不良反应。结论首诊时血清高水平PSA前列腺癌患者临床中较为少见,患者大多高龄,且较早出现骨骼等远处脏器转移,预后差,需行内分泌治疗、放射治疗、化学治疗等综合治疗方法,而早期诊断、早期治疗仍是影响预后及存活的重要因素。
[Abstract]:Objective To study the clinical features and diagnosis and treatment methods of patients with advanced prostate specific antigen ( PSA ) type prostate cancer , and to improve the diagnosis and treatment level of patients with prostate cancer .
There were 9 cases ( 32 . 1 % ) with ED and the symptoms of sexual desire loss after medication , combined with the age of the elderly and other factors , were not treated ;
7 ( 25 % ) patients had facial flushing , and the side effects were significantly reduced after 1 month .
In 2 cases ( 7.1 % ) , insulin resistance was found , and it was suggested to be treated with oral medication and the patient ' s blood glucose was normal .
One ( 3.6 % ) patients developed male breast development , symptoms disappeared after 3 months . 12 patients were treated with 125I seeds at the same time , 10 patients were treated with disease control after treatment . Two other diseases progressed , left kidney and pelvic lymph node metastasis respectively , and both were treated with docetaxel based chemotherapy regimen .
There were 5 cases with mild to moderate lower urinary tract symptoms ( LUTS ) and discomfort in the vaginal area after 125I treatment . There were 3 cases with rectal bleeding symptoms of temporary defecation habit change or internal emergency , and 2 cases had serious adverse reactions such as urethral stricture and rectal prostatic fistula . Among the 28 patients , only 1 case had original bone lesions and new bone metastasis .
Of the 13 patients treated with disodium ocephosphonate , there were 4 patients with new bone lesions in the course of treatment , and other 9 patients had no skeletal lesions , and there were no statistically significant effects on the protection of bone compared to the two methods ( P > 0.05 ) .
In 1 case ( 3.6 % ) , diarrhea occurred in the initial stage of chemotherapy , and the symptoms disappeared after treatment .
1 case ( 3.6 % ) had numbness of limbs , 3 - 6 days after chemotherapy , the symptoms disappeared ;
There were no other adverse reactions . 6 patients with new bone lesions were treated with " Yin Fu + 89 strontium " , and the patients died in the follow - up period of 6 to 48 months . The patients died of myocardial infarction due to liver failure . One patient died of cardiac failure ( 3.6 % ) . One patient died of cardiac failure . One patient died of cardiac failure . One patient died of cardiac failure . One patient died of cardiac failure . One patient died of cardiac failure . One patient died of cardiac failure . The prognosis was poor . Early diagnosis was still an important factor affecting the prognosis and survival .
【学位授予单位】:河南大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R737.25

【参考文献】

相关期刊论文 前9条

1 李春媚;陈敏;李飒英;王文超;赵伟峰;杨正汉;刘明;周诚;;前列腺癌的MRI诊断:T2WI、DWI、MRS及其综合应用[J];磁共振成像;2010年04期

2 张帆;黄毅;马潞林;王俊杰;冉维强;;~(125)I放射性粒子植入治疗C期激素难治性前列腺癌[J];中国男科学杂志;2010年07期

3 张建国;王艳丽;李静;;唑来磷酸联合~(89)Sr治疗前列腺癌骨转移[J];现代泌尿生殖肿瘤杂志;2010年05期

4 任晓敏;应俊;姚德鸿;叶传扬;姚海军;;~(89)锶联合内分泌疗法治疗前列腺癌骨转移疼痛的疗效观察[J];中国全科医学;2007年08期

5 冯宇;;因卡膦酸二钠治疗骨转移癌的临床研究[J];中国药物应用与监测;2011年04期

6 刘振伟,项永兵,张薇,方茹蓉,阮志贤,孙璐,高立峰,金凡,高玉堂;上海市区1973~1999年前列腺癌发病趋势分析[J];中国卫生统计;2003年06期

7 罗国平,孙达;~(89)SrCl_2治疗转移性骨肿瘤的临床应用[J];中华核医学杂志;2001年01期

8 肖城生;钟狂飚;;多西他赛联合顺铂治疗晚期激素非依赖性前列腺癌的临床分析[J];中国民康医学;2012年20期

9 赵强;王琳;窦红芹;郑国昌;;多西紫杉醇联合雌二醇氮芥治疗晚期雄激素非依赖性前列腺癌临床疗效评价[J];疑难病杂志;2013年08期



本文编号:2132617

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/mjlw/2132617.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户ea5b9***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com